Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Questioning the value of screening for prostate cancer in asymptomatic men.

Urology

Chodak GW.
PMID: 8367919
Urology. 1993 Aug;42(2):116-8. doi: 10.1016/0090-4295(93)90633-l.

No abstract available.

Cite
Chodak GW. Questioning the value of screening for prostate cancer in asymptomatic men. Urology. 1993;42(2):116-8doi: 10.1016/0090-4295(93)90633-l.
Chodak, G. W. (1993). Questioning the value of screening for prostate cancer in asymptomatic men. Urology, 42(2), 116-8. https://doi.org/10.1016/0090-4295(93)90633-l
Chodak, G W. "Questioning the value of screening for prostate cancer in asymptomatic men." Urology vol. 42,2 (1993): 116-8. doi: https://doi.org/10.1016/0090-4295(93)90633-l
Chodak GW. Questioning the value of screening for prostate cancer in asymptomatic men. Urology. 1993 Aug;42(2):116-8. doi: 10.1016/0090-4295(93)90633-l. PMID: 8367919.
Copy Download .nbib Format: NLM
[International comparisons of prostate cancer incidence and mortality].

Nihon rinsho. Japanese journal of clinical medicine

Kuroishi T.
PMID: 11022679
Nihon Rinsho. 2000 Jul;58:12-21.

No abstract available.

Cite
Kuroishi T. [International comparisons of prostate cancer incidence and mortality]. Nihon Rinsho. 2000;58:12-21
Kuroishi, T. (2000). [International comparisons of prostate cancer incidence and mortality]. Nihon rinsho. Japanese journal of clinical medicine, 5812-21.
Kuroishi, T. "[International comparisons of prostate cancer incidence and mortality]." Nihon rinsho. Japanese journal of clinical medicine vol. 58 (2000): 12-21.
Kuroishi T. [International comparisons of prostate cancer incidence and mortality]. Nihon Rinsho. 2000 Jul;58:12-21. Japanese. PMID: 11022679.
Copy Download .nbib Format: NLM
Marital status and survival in prostate cancer.

Harvard men's health watch

[No authors listed]
PMID: 9699477
Harv Mens Health Watch. 1998 Aug;3(1):7-8.

No abstract available.

Cite
Marital status and survival in prostate cancer. Harv Mens Health Watch. 1998;3(1):7-8
(1998). Marital status and survival in prostate cancer. Harvard men's health watch, 3(1), 7-8.
"Marital status and survival in prostate cancer." Harvard men's health watch vol. 3,1 (1998): 7-8.
Marital status and survival in prostate cancer. Harv Mens Health Watch. 1998 Aug;3(1):7-8. PMID: 9699477.
Copy Download .nbib Format: NLM
Prostate cancer mortality rates by prefectures in Japan.

Japanese journal of clinical oncology

Yamamoto S.
PMID: 11302349
Jpn J Clin Oncol. 2001 Feb;31(2):91.

No abstract available.

Cite
Yamamoto S. Prostate cancer mortality rates by prefectures in Japan. Jpn J Clin Oncol. 2001;31(2):91
Yamamoto, S. (2001). Prostate cancer mortality rates by prefectures in Japan. Japanese journal of clinical oncology, 31(2), 91.
Yamamoto, S. "Prostate cancer mortality rates by prefectures in Japan." Japanese journal of clinical oncology vol. 31,2 (2001): 91.
Yamamoto S. Prostate cancer mortality rates by prefectures in Japan. Jpn J Clin Oncol. 2001 Feb;31(2):91. PMID: 11302349.
Copy Download .nbib Format: NLM
[Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study].

Nederlands tijdschrift voor geneeskunde

Schröder FH, Roobol MJ, Bangma CH.
PMID: 25850455
Ned Tijdschr Geneeskd. 2015;159:A8677.

The recent publication of updated results from the European randomised study of screening for prostate cancer (ERSPC) with a median 13-year follow-up confirms significant relative and absolute reductions in prostate cancer mortality. In spite of existing guidelines, Dutch men...

Cite
Schröder FH, Roobol MJ, Bangma CH. Vroege opsporing van prostaatkanker--aanbevelingen na 13 jaar follow-up in de Europese gerandomiseerde studie. [Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study]. Ned Tijdschr Geneeskd. 2015;159:A8677
Schröder, F. H., Roobol, M. J., & Bangma, C. H. (2015). Vroege opsporing van prostaatkanker--aanbevelingen na 13 jaar follow-up in de Europese gerandomiseerde studie. [Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study]. Nederlands tijdschrift voor geneeskunde, 159A8677.
Schröder, Fritz H, et al. "Vroege opsporing van prostaatkanker--aanbevelingen na 13 jaar follow-up in de Europese gerandomiseerde studie." [Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study]. Nederlands tijdschrift voor geneeskunde vol. 159 (2015): A8677.
Schröder FH, Roobol MJ, Bangma CH. Vroege opsporing van prostaatkanker--aanbevelingen na 13 jaar follow-up in de Europese gerandomiseerde studie. [Early detection of prostate cancer--recommendations after 13 years of follow-up in the European randomised study]. Ned Tijdschr Geneeskd. 2015;159:A8677. Dutch. PMID: 25850455.
Copy Download .nbib Format: NLM
Editorial comment.

Urology

Prasad SM, Sartor AO, Bennett CL.
PMID: 24238571
Urology. 2014 Jan;83(1):152-3; discussion 153. doi: 10.1016/j.urology.2013.08.085. Epub 2013 Nov 12.

No abstract available.

Cite
Prasad SM, Sartor AO, Bennett CL. Editorial comment. Urology. 2013;83(1):152-3; discussion 153doi: 10.1016/j.urology.2013.08.085.
Prasad, S. M., Sartor, A. O., & Bennett, C. L. (2014). Editorial comment. Urology, 83(1), 152-3; discussion 153. https://doi.org/10.1016/j.urology.2013.08.085
Prasad, Sandip M, et al. "Editorial comment." Urology vol. 83,1 (2014): 152-3; discussion 153. doi: https://doi.org/10.1016/j.urology.2013.08.085
Prasad SM, Sartor AO, Bennett CL. Editorial comment. Urology. 2014 Jan;83(1):152-3; discussion 153. doi: 10.1016/j.urology.2013.08.085. Epub 2013 Nov 12. PMID: 24238571.
Copy Download .nbib Format: NLM
Re: Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.

The Journal of urology

Griebling TL.
PMID: 25895769
J Urol. 2015 May;193(5):1543-4. doi: 10.1016/j.juro.2015.02.049. Epub 2015 Feb 18.

No abstract available.

Cite
Griebling TL. Re: Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. J Urol. 2015;193(5):1543-4doi: 10.1016/j.juro.2015.02.049.
Griebling, T. L. (2015). Re: Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. The Journal of urology, 193(5), 1543-4. https://doi.org/10.1016/j.juro.2015.02.049
Griebling, Tomas L. "Re: Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology." The Journal of urology vol. 193,5 (2015): 1543-4. doi: https://doi.org/10.1016/j.juro.2015.02.049
Griebling TL. Re: Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. J Urol. 2015 May;193(5):1543-4. doi: 10.1016/j.juro.2015.02.049. Epub 2015 Feb 18. PMID: 25895769.
Copy Download .nbib Format: NLM
Optimizing the management of prostate diseases: prostate cancer. Introduction.

BJU international

Fitzpatrick JM.
PMID: 18307684
BJU Int. 2008 Mar;101:1. doi: 10.1111/j.1464-410X.2007.07484.x.

No abstract available.

Cite
Fitzpatrick JM. Optimizing the management of prostate diseases: prostate cancer. Introduction. BJU Int. 2008;101:1doi: 10.1111/j.1464-410X.2007.07484.x.
Fitzpatrick, J. M. (2008). Optimizing the management of prostate diseases: prostate cancer. Introduction. BJU international, 1011. https://doi.org/10.1111/j.1464-410X.2007.07484.x
Fitzpatrick, John M. "Optimizing the management of prostate diseases: prostate cancer. Introduction." BJU international vol. 101 (2008): 1. doi: https://doi.org/10.1111/j.1464-410X.2007.07484.x
Fitzpatrick JM. Optimizing the management of prostate diseases: prostate cancer. Introduction. BJU Int. 2008 Mar;101:1. doi: 10.1111/j.1464-410X.2007.07484.x. PMID: 18307684.
Copy Download .nbib Format: NLM
Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies.

Urologia internationalis

Golabek T, Bukowczan J, Chłosta P, Powroźnik J, Dobruch J, Borówka A.
PMID: 23942223
Urol Int. 2014;92(1):7-14. doi: 10.1159/000351325. Epub 2013 Aug 08.

BACKGROUND: There has been a large body of research on obesity and the risk of prostate cancer (PCa) that has been published recently. However, the epidemiological evidence for such an association has not been consistent. This may be attributed...

Cite
Golabek T, Bukowczan J, Chłosta P, et al. Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urol Int. 2013;92(1):7-14doi: 10.1159/000351325.
Golabek, T., Bukowczan, J., Chłosta, P., Powroźnik, J., Dobruch, J., & Borówka, A. (2014). Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urologia internationalis, 92(1), 7-14. https://doi.org/10.1159/000351325
Golabek, Tomasz, et al. "Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies." Urologia internationalis vol. 92,1 (2014): 7-14. doi: https://doi.org/10.1159/000351325
Golabek T, Bukowczan J, Chłosta P, Powroźnik J, Dobruch J, Borówka A. Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urol Int. 2014;92(1):7-14. doi: 10.1159/000351325. Epub 2013 Aug 08. PMID: 23942223.
Copy Download .nbib Format: NLM
Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancer.

Annals of internal medicine

Daskivich TJ, Litwin MS, Penson DF.
PMID: 24026326
Ann Intern Med. 2013 Sep 03;159(5):370. doi: 10.7326/0003-4819-159-5-201309030-00018.

No abstract available.

Cite
Daskivich TJ, Litwin MS, Penson DF. Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancer. Ann Intern Med. 2013;159(5):370doi: 10.7326/0003-4819-159-5-201309030-00018.
Daskivich, T. J., Litwin, M. S., & Penson, D. F. (2013). Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancer. Annals of internal medicine, 159(5), 370. https://doi.org/10.7326/0003-4819-159-5-201309030-00018
Daskivich, Timothy J, et al. "Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancer." Annals of internal medicine vol. 159,5 (2013): 370. doi: https://doi.org/10.7326/0003-4819-159-5-201309030-00018
Daskivich TJ, Litwin MS, Penson DF. Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancer. Ann Intern Med. 2013 Sep 03;159(5):370. doi: 10.7326/0003-4819-159-5-201309030-00018. PMID: 24026326.
Copy Download .nbib Format: NLM
Androgen deprivation therapy is ineffective for early prostate cancer, US study shows.

BMJ (Clinical research ed.)

Mayor S.
PMID: 24652998
BMJ. 2014 Mar 19;348:g2230. doi: 10.1136/bmj.g2230.

No abstract available.

Cite
Mayor S. Androgen deprivation therapy is ineffective for early prostate cancer, US study shows. BMJ. 2014;348:g2230doi: 10.1136/bmj.g2230.
Mayor, S. (2014). Androgen deprivation therapy is ineffective for early prostate cancer, US study shows. BMJ (Clinical research ed.), 348g2230. https://doi.org/10.1136/bmj.g2230
Mayor, Susan. "Androgen deprivation therapy is ineffective for early prostate cancer, US study shows." BMJ (Clinical research ed.) vol. 348 (2014): g2230. doi: https://doi.org/10.1136/bmj.g2230
Mayor S. Androgen deprivation therapy is ineffective for early prostate cancer, US study shows. BMJ. 2014 Mar 19;348:g2230. doi: 10.1136/bmj.g2230. PMID: 24652998.
Copy Download .nbib Format: NLM
Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor.

Cancer

Printz C.
PMID: 32776531
Cancer. 2020 Sep 01;126(17):3893-3894. doi: 10.1002/cncr.33127.

No abstract available.

Cite
Printz C. Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor. Cancer. 2020;126(17):3893-3894doi: 10.1002/cncr.33127.
Printz, C. (2020). Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor. Cancer, 126(17), 3893-3894. https://doi.org/10.1002/cncr.33127
Printz, Carrie. "Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor." Cancer vol. 126,17 (2020): 3893-3894. doi: https://doi.org/10.1002/cncr.33127
Printz C. Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor. Cancer. 2020 Sep 01;126(17):3893-3894. doi: 10.1002/cncr.33127. PMID: 32776531.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries